Benjamin F. Mcgraw III - Sep 20, 2021 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Interim Executive Chair, Director
Signature
s/ John LaRocca, Attorney-in-Fact for Benjamin F. McGraw, III
Stock symbol
AERI
Transactions as of
Sep 20, 2021
Transactions value $
$0
Form type
4
Date filed
9/22/2021, 05:40 PM
Previous filing
Jun 21, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +34.5K +298.81% $0.00 46.1K Sep 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +102K $0.00 102K Sep 20, 2021 Common Stock 102K $11.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, these shares of Common Stock are scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.
F2 Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, this option is scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.